These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33865458)

  • 1. Improvements in cholesterol efflux capacity of HDL and adiponectin contribute to mitigation in cardiovascular disease risk after bariatric surgery in a cohort with morbid obesity.
    Thakkar H; Vincent V; Shukla S; Sra M; Kanga U; Aggarwal S; Singh A
    Diabetol Metab Syndr; 2021 Apr; 13(1):46. PubMed ID: 33865458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between circulating adipokines and cholesterol efflux in subjects with severe carotid atherosclerosis.
    Gasbarrino K; Hafiane A; Gianopoulos I; Zheng H; Mantzoros CS; Daskalopoulou SS
    Metabolism; 2023 Mar; 140():155381. PubMed ID: 36566801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin Predicts High-Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat Distribution.
    Marsche G; Zelzer S; Meinitzer A; Kern S; Meissl S; Pregartner G; Weghuber D; Almer G; Mangge H
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4117-4123. PubMed ID: 28938424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity.
    Kjellmo CA; Karlsson H; Nestvold TK; Ljunggren S; Cederbrant K; Marcusson-Ståhl M; Mathisen M; Lappegård KT; Hovland A
    J Clin Lipidol; 2018; 12(1):193-202. PubMed ID: 29146227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy".
    Appachi S; Kelly KR; Schauer PR; Kirwan JP; Hazen S; Gupta M; Kashyap SR
    Obes Surg; 2011 Dec; 21(12):1928-36. PubMed ID: 21625910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.
    Josefs T; Wouters K; Tietge UJF; Annema W; Dullaart RPF; Vaisar T; Arts ICW; van der Kallen CJH; Stehouwer CDA; Schalkwijk CG; Goldberg IJ; Fisher EA; van Greevenbroek MMJ
    J Clin Lipidol; 2020; 14(1):122-132.e4. PubMed ID: 31791716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women.
    Greco D; Kocyigit D; Adorni MP; Marchi C; Ronda N; Bernini F; Gurses KM; Canpinar H; Guc D; Oguz SH; Gurlek A; Strazzella A; Simonelli S; Tokgozoglu L; Zimetti F
    Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):822-829. PubMed ID: 29954641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.
    Boyer M; Mitchell PL; Poirier P; Alméras N; Tremblay A; Bergeron J; Després JP; Arsenault BJ
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E460-E468. PubMed ID: 29870675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
    Maraninchi M; Padilla N; Béliard S; Berthet B; Nogueira JP; Dupont-Roussel J; Mancini J; Bégu-Le Corroller A; Dubois N; Grangeot R; Mattei C; Monclar M; Calabrese A; Guérin C; Desmarchelier C; Nicolay A; Xiao C; Borel P; Lewis GF; Valéro R
    J Clin Lipidol; 2017; 11(2):495-506.e3. PubMed ID: 28502507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immediate post op and follow up assessment of circulating adipo-cytokines after bariatric surgery in morbid obesity.
    Sachan A; Singh A; Shukla S; Aggarwal S; Mir I; Yadav R
    Metabol Open; 2022 Mar; 13():100147. PubMed ID: 34993466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass.
    Geloneze B; Pereira JA; Pareja JC; Lima MM; Lazarin MA; Souza IC; Tambascia MA; Chaim E; Muscelli E
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):293-300. PubMed ID: 19466223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control.
    Denimal D; Monier S; Simoneau I; Duvillard L; Vergès B; Bouillet B
    Cardiovasc Diabetol; 2022 Aug; 21(1):154. PubMed ID: 35962339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess weight mediates changes in HDL pool that reduce cholesterol efflux capacity and increase antioxidant activity.
    de Lima-Junior JC; Virginio VWM; Moura FA; Bertolami A; Bertolami M; Coelho-Filho OR; Zanotti I; Nadruz W; de Faria EC; de Carvalho LSF; Sposito AC
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):254-264. PubMed ID: 31753789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery.
    Ooi GJ; Earnest A; Doyle L; Laurie C; Wentworth JM; Sikaris K; le Roux CW; Burton PR; O'Brien PE; Brown WA
    Obes Surg; 2018 May; 28(5):1351-1362. PubMed ID: 29159554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer.
    Fernández-Castillejo S; Rubió L; Hernáez Á; Catalán Ú; Pedret A; Valls RM; Mosele JI; Covas MI; Remaley AT; Castañer O; Motilva MJ; Solá R
    Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28887843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis.
    Qiu C; Zhao X; Zhou Q; Zhang Z
    Lipids Health Dis; 2017 Nov; 16(1):212. PubMed ID: 29126414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL functions and their interaction in patients with ST elevation myocardial infarction: a case control study.
    Thakkar H; Vincent V; Roy A; Singh S; Ramakrishnan L; Kalaivani M; Singh A
    Lipids Health Dis; 2020 Apr; 19(1):75. PubMed ID: 32293456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
    Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.